Bruce E. Blough

6.1k total citations
176 papers, 4.8k citations indexed

About

Bruce E. Blough is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Toxicology. According to data from OpenAlex, Bruce E. Blough has authored 176 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 128 papers in Cellular and Molecular Neuroscience, 74 papers in Molecular Biology and 50 papers in Toxicology. Recurrent topics in Bruce E. Blough's work include Neurotransmitter Receptor Influence on Behavior (113 papers), Forensic Toxicology and Drug Analysis (47 papers) and Receptor Mechanisms and Signaling (38 papers). Bruce E. Blough is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (113 papers), Forensic Toxicology and Drug Analysis (47 papers) and Receptor Mechanisms and Signaling (38 papers). Bruce E. Blough collaborates with scholars based in United States, South Korea and Singapore. Bruce E. Blough's co-authors include Michael H. Baumann, Richard B. Rothman, John S. Partilla, Matthew L. Banks, S. Stevens Negus, F. Ivy Carroll, Julie A. Marusich, Hernán A. Navarro, Jenny L. Wiley and Ann M. Decker and has published in prestigious journals such as Journal of Biological Chemistry, Chemical Communications and Scientific Reports.

In The Last Decade

Bruce E. Blough

170 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bruce E. Blough United States 38 2.8k 1.7k 1.5k 1.1k 684 176 4.8k
John S. Partilla United States 39 3.7k 1.3× 2.0k 1.2× 2.3k 1.5× 1.7k 1.5× 715 1.0× 135 5.5k
Aaron Janowsky United States 43 3.5k 1.3× 2.6k 1.5× 521 0.3× 473 0.4× 649 0.9× 129 5.5k
William E. Fantegrossi United States 39 2.4k 0.9× 637 0.4× 2.1k 1.4× 1.5k 1.4× 1.6k 2.4× 109 3.9k
Vincent Setola United States 33 1.8k 0.6× 2.8k 1.6× 317 0.2× 471 0.4× 676 1.0× 81 5.1k
Justin L. Poklis United States 37 1.3k 0.5× 840 0.5× 1.2k 0.8× 763 0.7× 1.4k 2.1× 144 3.8k
Christina M. Dersch United States 31 2.4k 0.9× 1.8k 1.0× 423 0.3× 337 0.3× 459 0.7× 107 3.5k
Michael B. Gatch United States 30 1.5k 0.5× 592 0.3× 667 0.4× 722 0.6× 349 0.5× 80 2.5k
F. Ivy Carroll United States 50 4.5k 1.6× 4.4k 2.6× 662 0.4× 330 0.3× 1.1k 1.5× 305 8.0k
Samuel D. Banister Australia 33 1.4k 0.5× 1.1k 0.6× 1.6k 1.0× 488 0.4× 2.0k 2.9× 99 3.5k
Matteo Marti Italy 36 2.8k 1.0× 1.5k 0.9× 914 0.6× 390 0.3× 686 1.0× 146 3.8k

Countries citing papers authored by Bruce E. Blough

Since Specialization
Citations

This map shows the geographic impact of Bruce E. Blough's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce E. Blough with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce E. Blough more than expected).

Fields of papers citing papers by Bruce E. Blough

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bruce E. Blough. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce E. Blough. The network helps show where Bruce E. Blough may publish in the future.

Co-authorship network of co-authors of Bruce E. Blough

This figure shows the co-authorship network connecting the top 25 collaborators of Bruce E. Blough. A scholar is included among the top collaborators of Bruce E. Blough based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce E. Blough. Bruce E. Blough is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Rajnikant, Vincenzo Carbone, Leslie M. Hicks, et al.. (2025). A novel role for colistin as an efflux pump inhibitor in multidrug-resistant Klebsiella pneumoniae. Scientific Reports. 15(1). 34612–34612. 1 indexed citations
2.
Liu, Xiaobo, Mònica Aguilera, Abdul N. Hamood, et al.. (2025). Molecular mechanisms of 10-butyl ether minocycline, a novel nonantibiotic tetracycline, as a potential treatment for inflammatory and neuroimmune-related disorders. Journal of Pharmacology and Experimental Therapeutics. 392(11). 103748–103748.
3.
Tyler, Ryan E., et al.. (2024). mGlu2 and mGlu3 receptor negative allosteric modulators attenuate the interoceptive effects of alcohol in male and female rats. Pharmacology Biochemistry and Behavior. 239. 173767–173767.
4.
Liu, Xiaobo, Sambantham Shanmugam, Bruce E. Blough, et al.. (2024). 10-Butyl Ether Minocycline Reduced High Alcohol Consumption in a Dependence Mouse Model. Alcoholism Treatment Quarterly. 43(1). 76–87. 1 indexed citations
6.
Beerepoot, Pieter, Reza Nazari, Dong Han, et al.. (2022). Structure-Activity Relationships of Dopamine Transporter Pharmacological Chaperones. Frontiers in Cellular Neuroscience. 16. 832536–832536. 9 indexed citations
9.
Czoty, Paul W., et al.. (2020). Evaluation of the Reinforcing Strength of Phendimetrazine Using a Progressive-Ratio Schedule of Reinforcement in Rhesus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 374(1). 1–5. 8 indexed citations
10.
Blough, Bruce E., et al.. (2019). The synthetic cathinone psychostimulant α‐PPP antagonizes serotonin 5‐HT2A receptors: In vitro and in vivo evidence. Drug Testing and Analysis. 11(7). 990–998. 7 indexed citations
11.
Decker, Ann M., Agnieszka Sulima, Kenner C. Rice, et al.. (2018). Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. Neuropharmacology. 142. 240–250. 44 indexed citations
12.
Walsh, Kenneth B., et al.. (2017). N-(2-methoxyphenyl) benzenesulfonamide, a novel regulator of neuronal G protein-gated inward rectifier K + channels. European Journal of Pharmacology. 815. 233–240. 1 indexed citations
13.
Kohut, Stephen J., David S. Jacobs, Richard B. Rothman, et al.. (2017). Cocaine-like discriminative stimulus effects of “norepinephrine-preferring” monoamine releasers: time course and interaction studies in rhesus monkeys. Psychopharmacology. 234(23-24). 3455–3465. 8 indexed citations
14.
Smith, Douglas A., Bruce E. Blough, & Matthew L. Banks. (2016). Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys. Psychopharmacology. 234(1). 117–127. 14 indexed citations
15.
Reith, Maarten E. A., Bruce E. Blough, Weimin Hong, et al.. (2014). Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Drug and Alcohol Dependence. 147. 1–19. 108 indexed citations
16.
Blough, Bruce E., Antonio Landavazo, John S. Partilla, et al.. (2014). Alpha-ethyltryptamines as dual dopamine–serotonin releasers. Bioorganic & Medicinal Chemistry Letters. 24(19). 4754–4758. 29 indexed citations
17.
Banks, Matthew L., Bruce E. Blough, Richard B. Rothman, et al.. (2014). Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys.. Experimental and Clinical Psychopharmacology. 22(3). 274–284. 16 indexed citations
18.
Rothman, Richard B., Michael H. Baumann, Bruce E. Blough, et al.. (2010). Evidence for noncompetitive modulation of substrate‐induced serotonin release. Synapse. 64(11). 862–869. 15 indexed citations
19.
Rothman, Richard B., Bruce E. Blough, & Michael H. Baumann. (2006). Dual dopamine–5-HT releasers: potential treatment agents for cocaine addiction. Trends in Pharmacological Sciences. 27(12). 612–618. 35 indexed citations
20.
Wee, Sunmee, et al.. (2005). Relationship between the Serotonergic Activity and Reinforcing Effects of a Series of Amphetamine Analogs. Journal of Pharmacology and Experimental Therapeutics. 313(2). 848–854. 165 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026